发明名称 Compounds for Alzheimer's disease
摘要 The present disclosure relates to novel indole and tetrahydroindole core compounds useful for the treatment of disorders associated with a defect in vesicular transport (e.g., axonal transport).
申请公布号 US9216966(B2) 申请公布日期 2015.12.22
申请号 US201313801348 申请日期 2013.03.13
申请人 发明人 Gassman Andrew D.;Klein Christine;Bhoite Leena;Manfredi John;Slade Rachel M.;Klimova Yevgeniya;Halter Robert J.;Yungai Ashantai J.;Weiner Warren S.;Walton Ruth J.;Willardsen Jon Adam;Anderson Mark B.;Zavitz Kenton
分类号 A61K31/405;A61K31/427;A61K31/341;A61K31/4439;C07D209/10;C07D277/28;C07D307/38;C07D403/04;C07D413/10;C07D401/04;C07D405/04;C07D417/04;C07D401/14;C07D405/14;C07D413/14;C07D231/12;C07D403/10;C07D409/04;C07D409/14;C07D413/04;C07D491/10;C07D209/08;C07D209/14;C07D209/60;C07F7/18;C07F7/08 主分类号 A61K31/405
代理机构 Stoel Rives LLP 代理人 Ley, III Herbert L.;Stoel Rives LLP
主权项 1. A compound with the structure of Formula (XVII): wherein R6, R6′, R7, R7′, R8, R8′, R9, R9′ and R10 are independently selected from at least one of hydro, hydroxyl, halo, alkyl, alkoxy, haloalkyl, haloalkoxy, —N(C1-3 alkyl)2, —NH(C1-3 alkyl), —C(═O)NH2, —C(═O)NH(C1-3 alkyl), —C(═O)N(C1-3 alkyl)2, —S(═O)2(C1-3 alkyl), —S(═O)2NH2, —S(═O)2N(C1-3 alkyl)2, —S(═O)2NH(C1-3 alkyl), —CHF2, —OCF3, —OCHF2, —SCF3, —CF3, —CN, —NH2, and —NO2; R20 is aryl or heteroaryl; and R21 is heteroaryl; or a pharmaceutically-acceptable salt thereof, with the proviso that when R6, R6′, R7, R7′, R8, R8′, R9, R9′ and R10 are all hydro and R20 is unsubstituted phenyl, the compound is not 2-phenyl-1-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-indole; and with the proviso that when R9 is OH, R9′ is hydro, R7 and R7′ are each methyl, and the compound is not 6,6-dimethyl-2-phenyl-1-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-indol-4-ol.
地址 Salt Lake City UT US